Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-24 | Ms. Capps is currently a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare focused private equity firm... She previously served as Chief Financial Officer of DJO Global, Inc.... Ms. Capps earned her bachelor’s degree from San Diego State University, is a California Certified Public Accountant. |
| 2021-04-28 | Ms. Capps is a certified public accountant, a former chief financial officer and has been designated as one of our “Audit Committee Financial Experts” on our Audit Committee. |
| 2022-04-27 | Ms. Capps is currently a member of the board of directors and the audit committee chair of each of NuVasive, Inc., a public medical device company and three public small-cap, pre-commercial biopharmaceutical companies... Ms. Capps earned her bachelors degree from San Diego State University, is a California Certified Public Accountant and was recognized as a CFO of the Year honoree. |
| 2023-04-27 | Ms. Capps is a certified public accountant, a former chief financial officer and has been designated as our “Audit Committee Financial Expert” on our Audit Committee. Ms. Capps has extensive experience in the healthcare industry, having served as chief financial officer of a medical device and service company for 11 years as well as service on numerous public and private company boards of directors in the healthcare industry. |
| 2024-12-10 | Ms. Capps is currently a member of the board of directors and the audit committee chair of each of Janux Therapeutics, Inc., a public, pre-commercial biopharmaceutical company, Enable Injections, Inc., a private medical device company, and Breg, Inc., a private medical device company. She is also a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare focused private equity firm, and she served on the board of directors of its portfolio company, Enclara Pharmacia, a provider of pharmacy services to the hospice industry, prior to its acquisition by Humana in January 2020. She previously served as Chief Financial Officer of DJO Global, Inc. from 2002 through 2013 and as a member of the boards of directors of NuVasive, Inc., a public medical device company, prior to its merger with Globus Medical in September 2023, Otonomy, Inc., a public biotechnology company, prior to its voluntary liquidation and dissolution in March 2023, Silverback Therapeutics, Inc., a public biotechnology company, prior to its merger with ARS Pharmaceuticals, Inc. in November 2022, Synthorx, Inc., a public biotechnology company, prior to its acquisition by Sanofi in January 2020, Connecture, Inc. prior to its being taken private by Francisco Partners in April 2018, RF Surgical Systems prior to its acquisition by Medtronic in August 2015 and SenoRx, prior to its acquisition by C. R. Bard, Inc. in July 2010. She is also a member of the board of directors of the San Diego State University Research Foundation. Earlier in her career, Ms. Capps spent 10 years as an audit and accounting professional with Ernst & Young and then served as the chief financial officer of several public and private companies. Ms. Capps earned her bachelor’s degree from San Diego State University, is a California Certified Public Accountant and was recognized as a CFO of the Year honoree by the San Diego Business Journal in 2009 and 2010 and as a Director of the Year by the Corporate Directors Forum in 2022. |
Data sourced from SEC filings. Last updated: 2025-10-11